REGN stock

Regeneron Pharmaceuticals Inc (REGN) institutional holders · P/E 20, rev $14.34B

Regeneron Pharmaceuticals Inc 13F cache, top 3 holders by reported value. Each row is the filer's newest cached 13F for quarters ended 2026-06-30 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Filers whose newest cached 13F is older are omitted.

Cached 13F holders
HolderSharesValueReport
STATE STREET CORP4,834,688$3.01B2026-06-30
FMR LLC831,964$518.8M2026-06-30
Bridgewater Associates, LP51,333$32.0M2026-06-30
These 13F holders as JSON? API free 100/day

REGN institutional holders FAQ

How many REGN 13F holders are listed on this page?

This page lists 3 cached Regeneron Pharmaceuticals Inc (REGN) 13F holders. Holders: https://lician.com/institutional/regn

Who is the largest REGN 13F holder by reported value?

The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/regn/93751. Holders: https://lician.com/institutional/regn

What value and shares did the largest REGN 13F holder report?

STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 4,834,688 shares and a value of $3.01B.

What is the latest REGN 13F report date on this page?

The latest cached 13F report date on this Regeneron Pharmaceuticals Inc (REGN) holders table is Jun 30, 2026.

Which REGN 13F holders report the largest positions?

The largest cached 13F holders by reported value on this Regeneron Pharmaceuticals Inc (REGN) page are STATE STREET CORP, FMR LLC, and Bridgewater Associates, LP. Holders: https://lician.com/institutional/regn

Where are REGN institutional holders listed?

Cached 13F holders for Regeneron Pharmaceuticals Inc (REGN) are listed at https://lician.com/institutional/regn. Filer directory: https://lician.com/holders

What is REGN's P/E ratio?

Regeneron Pharmaceuticals Inc (REGN) trailing P/E is 19.9 on the latest cached fundamentals snapshot.

What is REGN's latest revenue?

Latest cached Regeneron Pharmaceuticals Inc (REGN) revenue for Dec 31, 2025 was $14.34B. Statements: https://lician.com/financials/regn

Not investment advice. Cached rows, not a live tape.